Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The trial will consist of a single treatment group enrolling adult subjects with CF on background therapy with KALYDECO®. Approximately 16 subjects will be enrolled.
Epistemonikos ID: d33ec28708a61864d99c23f06eb8687d379c2fed
First added on: May 21, 2024